The findings presented at the European Society of Cardiology (ESC) Congress in Barcelona by Dr Kuo-Yang Wang from Taiwan suggest that gender and age should be added to the risk stratification of resistant hypertension to enable more appropriate treatment decisions.
"Hypertension is one of the most important risk factors for cardiovascular disease. Patients with hypertension that do not respond to conventional drug treatments, called resistant hypertension, are at even higher risk of cardiovascular morbidity and mortality," Wang said.
"We aimed to discover the impact of resistant hypertension on Taiwanese patients, and to ascertain whether patient characteristics influence the association between resistant hypertension and adverse outcomes," said Wang.
Patients with hypertension aged 45 years and older were identified from the National Health Insurance Research Database. Medical records of 111,986 patients from 2000 to 2011 were reviewed for this study.
Some 16,402 (14.6 per cent) patients had resistant hypertension. The risk of major adverse cardiovascular events (MACE; a composite of all-cause mortality, acute coronary syndrome, and stroke) in patients with resistant hypertension and non-resistant hypertension was analysed.
When the researchers analysed the risk of different types of cardiovascular events separately they found that compared to patients with non-resistant hypertension, patients with resistant hypertension had a 17 per cent increased risk of stroke and a 34 per cent increased risk of ischaemic stroke but no increased risk of all-cause mortality or acute coronary syndrome.
"Our study shows that patients with resistant hypertension have higher risks for cardiovascular events than those with non-resistant hypertension. The elevated risks mainly contribute to increasing stroke events, especially ischaemic stroke," Wang said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
